Latest News and Press Releases

Alira Health today released its sixth annual report on the state of the contract development and manufacturing organization (CDMO) market in medtech.

Today, ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after the European...

Hyderabad, India, March 30, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the artificial intelligence in drug discovery market size was valued at USD 2.58 billion in 2025 and is...

Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204

Neion Bio exits stealth with first biosimilar co-development and supply partnership, leveraging its genetic engineering platform to enable scalable, lower-

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...

ProductLife Group appoints Dr. James Burt as CEO, strengthening global growth and capabilities across regulatory, clinical, quality and digital services.

Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric...